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Abstract Using a large stated preference survey conducted across the U.S. and
Canada, we assess differences in individual willingness to pay (WTP) for health risk
reductions between the two countries. Our utility-theoretic choice model allows for
systematically varying marginal utilities for avoided future time in different adverse
health states (illness-years, recovered/remission years, and lost life-years). We find
significant differences between Canadian and U.S. preferences. WTP also differs
systematically with age, gender, education, and marital status, as well as a number of
attitudinal and subjective health-perception variables. Age profiles for WTP are
markedly different across the two countries. Canadians tend to display flatter age
profiles, with peak WTP realized at older ages.
Keywords Willingness to pay for a microrisk reduction . Value of a statistical life
(VSL) . Stated preference . Health risks . International comparison
JEL classification Q51 . I18
Are there differences between the U.S. and Canada in how people value new
programs that reduce their health risks? If so, how large are these differences? Which
factors explain the observed differences? Specifically, are they explained simply by
differences in the socio-economic characteristics of people in each county? Or are
they due to subtle differences in basic preferences for risk protection? Or are they
due to measurable differences in individual health beliefs that arise from differences
in health care systems? If such beliefs are correlated with health care systems, they
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may shift individuals’ demands for privately available risk mitigation programs in
several ways. For example, they may influence individuals’ beliefs about their
subjective risks of experiencing various illnesses. They may also determine whether
a privately available risk reducing program is viewed as a substitute for, or as a
complement to, the individual’s existing health care system. Do such beliefs differ
across Canada and the U.S. and, if so, do they co-vary with demand for risk
reductions? In this paper, we offer initial answers to these questions through a
comparative analysis of demand for health risk reductions in both countries. Our
analysis should help researchers better understand, and perhaps anticipate, shifting
demand patterns for health risk management as Canada experiments with greater
privatization while the U.S. expands access to its publicly funded health care system.
Utilizing individual stated-preference data from virtually identical general-
population surveys conducted in both Canada and the United States, we estimate
models that investigate differences in average WTP for health risk reductions across
the two countries.1 In each country, we present respondents with sets of illness-
specific risk reduction programs for most of the major illnesses from which people
die. These programs involve diagnostic screening and, when illness risks are high,
medical therapies that would reduce their probability of experiencing that particular
future illness profile. Respondents pay an annual fee to participate in each risk-
reducing program. Our estimated models permit us to recover the implicit marginal
value of a sick-year or a lost life-year, as in a hedonic model.
As described in Section 1, the surveys we use collected data on numerous
determinants of WTP that are likely to vary between the U.S. and Canada, but which
would not be available using only hedonic wage-risk data for the two countries.2 For
example, the value of these risk-reduction programs should vary with the
individuals’ subjective risks of each type of illness. WTP for these additional risk-
reduction programs, which are described as being ineligible for coverage by health
insurance, should also vary with the individuals’ assessments of their opportunities
for averting behaviors (reduction in smoking, weight, more regular doctor visits,
etc.) which the individual could also (or alternatively) use to reduce their health
risks. Since the offered risk mitigation programs would be purchased outside of
respondents’ current health plans, WTP may also vary with their past experience in
going outside of their health plans. WTP for health risk reduction should also vary
with individuals’ perceptions of the effectiveness of the health care services that their
current plans could provide—both because current risk levels can be reduced ex ante
through preventive care and prospective illnesses can be more effectively treated.
Accounting for this kind of individual heterogeneity is important for several
reasons. First, controls for these individual characteristics are necessary to prevent
cross-national heterogeneity from showing up as spurious generic cross-national
differences (or a lack thereof) in health preferences. Second, any WTP number used
1 Although stated preference methods have generated controversy in the past because of concerns that
people would overstate their willingness to pay for a public risk reduction, over the past ten years
important strides have been made in understanding and minimizing concerns about their incentive
compatibility (List 2001). Indeed, meta-analyses have tended to show that stated preference estimates of
the demand for health risk reductions are systematically lower than those produced by revealed preference
data (Kochi et al. 2006).
2 Wage-risk studies are the predominant revealed-preference method for estimating the marginal rate of
substitution between mortality risks and money.
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for benefit-cost analysis should reflect the actual distribution of characteristics in the
at-risk population for a particular policy.
As we discuss in Section 2, based on the detailed attitudinal and subjective health
perception variables collected in our survey, we have identified a number of
variables for which the distribution (especially in relation to age) appears to differ
between the U.S. and Canada. For example, members of our Canadian sample
appear to express higher subjective probabilities associated with the risk of heart
disease, cancers, respiratory disease, diabetes, and Alzheimer’s disease. They are
also more inclined to say they could improve their health by quitting smoking and
improving their diet, but they are less inclined to believe they can reduce their risk of
traffic accidents through increased use of seat belts. Depending on age, they feel they
have more or less opportunity to improve their health by exercising more.
Given the different health-care institutions in the two countries—universal coverage
through provincial health plans in Canada, and the private-payer system with partial
coverage in the United States—individual perceptions can presumably differ about the
efficacy of health care and its overall accessibility. Our survey elicits information about
each individual’s confidence in diagnosis and treatment under their respective health
care systems. Moreover, the health risk reduction programs used in our stated choice
scenarios for Canadians were stipulated as being outside the normal course of care
under the provincial health plans, so information was also collected from each
individual about their personal experience with instances where they may have gone
outside their provincial health plan for prior medical diagnostic and testing services.
Section 3 outlines the utility-theoretic discrete choice model used in estimation.
This model is innovative in that it specifically includes latencies, sick-years, recovered/
remission-years and lost life-years associated with different prospective illness profiles
for which the individual may reduce their risk through purchase of a diagnostic test
and preventive treatments. Across choice sets, we vary the mix of attributes for the
different health risks and the resulting data permit us to estimate distinct marginal
utilities associated with discounted time in each health state. This marginal utility
information can be used to derive a corresponding inverse demand function for
reductions in the risk of experiencing a wide variety of different illness profiles.
Cross-country studies, such as this one, are typically motivated by one (or the
other) of two kinds of potential findings. Studies may reveal heretofore unknown
differences in the determinants of demand across the countries under study or they
may illuminate commonalities where differences were anticipated based on casual
empiricism. In Section 4, we control for age, gender, educational attainment and
marital status, as well as subjective health risks and several attitudinal variables, but
we still find numerous significant differences between Canadian and U.S.
respondents in the marginal value of risk reduction programs. In particular, the
effect of respondent age seems to differ substantially across the two countries.
However, peak WTP over age for Canadian males is much more similar to peak WTP
for U.S. males for those Canadians who have prior experience with out-of-plan
diagnostic testing (although the timing of the peaks remains different).3
3 Subjective health risks and health-related attitudes may be endogenous. Certainly, out-of-plan experience
is endogenous. These different preferences could account for why a particular respondent has gone outside
the provincial health care system in the past.
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In Section 5, we control for differences in income distributions across the two
countries and use simulation methods based on the joint distribution of our estimated
parameters to explore the influence of differences in attitudes and subjective health
perceptions on demand for mortality risk reductions specifically. The age profile of
WTP to reduce the risk of sudden death in the current period (the specific risk
reduction that maps most closely to measures estimated in the conventional
literature) seems to be remarkably different across the two countries. Canadians
have a flatter age profile of WTP to reduce risk of sudden death in the current period,
with peak WTP realized at a substantially older age (about 60 for Canadians
compared to about 35–40 for the U.S. sample). In this section, we also compare our
findings to those of other researchers (e.g. Aldy and Viscusi (2008)) who have
examined age profiles in willingness to pay for the U.S., both overall and per
discounted lost life-year.
Apparently only one previously published study has directly compared WTP
for health risk reductions between the U.S. and Canada.4 Alberini et al. (2004)
studied a sample of respondents from Hamilton, Ontario, and compared them to
another sample from the U.S. They find that Canadians have lower WTP, at least
for those aged 40 years and older. Although the Alberini et al. study allows for
systematic variation with age, the differences in WTP are not explained through
systematic variation across other sociodemographic characteristics, subjective
risks of the diseases in question, or differences between the Canadian and U.S.
health care systems. We extend this nascent cross-national literature to explain
observed differences in individual WTP for health risk reduction programs by
allowing for individual demand heterogeneity with respect to each of these
factors.5
In addition to the Alberini et al. work, there is an unpublished paper by Chestnut
et al. (2009) that also explores differences between the U.S. and Canada. Our work is
differentiated from this other study in that we employ greater utility-theoretic
structure in our model of preferences. Their study considers four types of health
threats, but does not model the future time profiles of symptoms associated with
these illnesses or injuries, nor does it distinguish between different types of health
states. Age is captured only as an indicator for the respondent being over 75 years
old. Due to the nature of their data, they devote considerably more attention to the
two different elicitation methods used in their study. Canadian and U.S. models are
estimated completely independently, and they conclude that none of the differences
in WTP across the two countries are statistically significant after adjusting for
4 Comparison of WTP for mortality risk reductions in the U.S. and Canada is also addressed in reports to
Cornell University and Health Canada from a study by Stratus Consulting. See Chestnut et al. (2003,
2004).
5 See Hammitt (2007) for an exposition on the opportunity for inclusion of systematic variation in WTP
studies. In addition to Alberini et al. (2004), Krupnick et al. (2002) identify variation in WTP across age of
the individuals, showing weak support for the notion that WTP for health risk reductions declines with
age. This is evidence of a “life-cycle effect,” where individuals expect to derive increasing marginal utility
from reducing health risks that come to bear later in their lives. In addition to the “life cycle effect,”
DeShazo and Cameron (2005) find statistical evidence that as people age, there is a systematic downward
shift in their anticipated schedule of marginal utility for risk reductions at future ages. Taken together,
these two effects offer evidence of time inconsistency: at younger ages, individuals seem to value future
health more, however, as they get older, they value future health less.
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currency differences. In contrast, we find statistically significant differences in
preferences and differing age profiles for WTP.
1 Survey design and data
Our two surveys, administered to general-population samples in the U.S. and
Canada, used survey instruments that were virtually identical (except for the
randomized portions which differed across choice occasions and across individuals).
This ensures that any observed differences in demand estimates across the two
countries are not artifacts solely of different survey questions or systematic
sampling. This stated preference survey was conducted first for Canadian residents
using the internet consumer panel maintained by Ipsos-Reid (selected so that the
proportions of the sample in different sociodemographic groups mimic the general
population). It was conducted again, a few months later, for the United States using
the representative consumer panel maintained by Knowledge Networks, Inc. The
administration of the Canadian survey allowed for collection of key demographic
information for Canadians that mirrors the demographic characteristics included in
Knowledge Network’s standing consumer panel for the United States. Information
on respondent age, income, educational attainment, marital status and gender is
available for both samples. The U.S. sample has been employed in Cameron and
DeShazo (2009), so only the highlights of the survey and sample properties will be
reviewed here.6
In addition to demographic characteristics, this survey collects four other categories
of information from each respondent. First, information is sought concerning the
individual’s personal health history and their perceptions of their likely susceptibility to
specific categories of major health risks. These questions ask about the respondent’s
own prior experience with the particular types of illnesses that they will subsequently be
asked to consider in a set of conjoint choice experiments. Respondents are also asked
about the prior experiences of friends and familymembers with these illnesses, about the
extent to which they believe these disease risks can be controlled through health habits
and lifestyle choices, and about their personal room to improve their health habits along
seven dimensions—including opportunities to see the doctor more regularly, to lose
weight, to exercise more, to drink less alcohol, to use a seat belt more, to eat a healthier
diet, and to quit smoking.7
6 For more information on the Cameron and DeShazo (2009) survey instrument and the U.S. sample of
data, see the comprehensive appendices which accompany that paper: Appendix A – Survey Design &
Development, Appendix B – Stated Preference Quality Assurance and Quality Control Checks, Appendix
C – Details of the Choice Set Design, Appendix D – The Knowledge Networks Panel and Sample
Selection Corrections, Appendix E – Model, Estimation and Alternative Analyses, and Appendix F –
Estimating Sample Codebook.
7 Although the nominal life expectancies used in the illness profiles for the survey’s choice experiments
were based upon actuarial life expectancies, we found in pre-tests that we had to add about eight years to
these actuarial expectancies to make them plausible. People tend to discount the age at death for relatives
who “died young” and to focus instead on their longest-living parents or grandparents. Respondents were
asked, at the end of the survey, to report their individual subjective life expectancy based on their health
and family history. (Our estimating specifications control for departures between individual’s subjective
life expectancy and the nominal life expectancy quoted in that individual’s choice questions.)
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The second part of the survey provides a risk tutorial and trains respondents about
how to interpret each of the attributes of the different risk reduction programs that
form the core of the survey. Respondents are required to answer a simple skill-
testing question to evaluate their comprehension of the notion of risk, since risk
comprehension is crucial to the choice tasks.
In the third and main section of the survey, after 24 pages of tutorials and
preparation, each respondent is presented with the first of five independent choice
scenarios. The first choice scenario presents all of the same quantitative information
used in the tutorial section in a simplified one-page “choice table.” See Fig. 1 for an
example.8 The individual is asked to evaluate two health programs, each offering a
reduction in a specified health risk at a monthly cost, against the status quo
alternative (i.e. no health risk reduction program, but no expense either). The
respondent is then asked to choose their most preferred option among the three
options available. Conditional on the respondent’s gender and current age, which
were known in advance, each of the two offered health programs involves a
randomly assigned reduction in the probability of getting sick or injured, and
describes the expected time-to-onset, duration, and potential for recovery from the
illness or injury, as well as the extent to which this health threat would shorten their
expected lifespan. Each illness profile is randomly assigned a disease name, subject
to a few exclusions for plausibility (e.g. no recovery from diabetes or Alzheimer’s
disease).9
For all disease risks (i.e. except for traffic accidents) each program reduces the
risk of disease incidence via a diagnostic pin-prick blood test administered once per
year by the individual’s doctor. The test would indicate whether the individual is at
risk of developing the illness in question. If so, the individual would be prescribed
medication and/or lifestyle changes to reduce the chance of suffering the illness
profile in question.10 Each risk reduction program is characterized specifically by a
reduction in the probability of illness, and the associated cost of the program (in both
annual terms and as monthly payments).
The final section of the survey consists of debriefing questions. Some of these are
posed directly after each choice scenario. Another question asks about the
respondent’s confidence that diagnosis and treatment by his/her current health care
provider would be both timely and of high quality. Debriefing questions also include
assessments of scenario “buy-in,” such as whether the individual believes they
would personally benefit from the risk reduction program, and the number of years
8 One complete version of the randomized survey instrument is archived in the supporting material for
Cameron and DeShazo (2009), under Appendix A – Survey Design & Development.
9 The range of possible configurations for illness profiles is defined by the individual’s age and gender. In
other work, we have found that the disease labels (regardless of the underlying illness profile) do affect
individual preferences to avoid adverse health states. These differences are addressed in Cameron et al.
(2008). However, the randomization of disease labels across illness profiles ensures that our point
estimates remain unbiased when we do not control for these differences. Any variation induced by
subjective beliefs about specific disease names would be essentially orthogonal to the illness profiles
considered in each scenario.
10 For traffic accident scenarios, the program was described as car equipment such as new airbags, braking
systems, and impact reduction technologies which could be retrofitted to existing vehicles, or included as
an option on new vehicle purchases, with capital costs amortized into monthly payments.
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into the future when they think they would “begin to value highly the risk reduction
benefits of each program” (which we interpret as the latency of the health threat).
For Canadian respondents, information is solicited about whether the individual has
previously sought care outside of their provincial health plan, since the health
programs used in the choice scenarios are described as extra-ordinary care which
would not be covered under their provincial health plan.11
The survey was administered to 2,439 respondents from the United States and
1,109 Canadians.12 Certain Canadian and U.S. respondents were excluded for three
main reasons. First, if the respondent did not correctly answer the risk
comprehension question, he or she was excluded from the analysis. Second, if the
Fig. 1 One randomization of a conjoint choice set (See online Appendix A to Cameron and DeShazo
(2009) for one version of the complete survey)
11 Through debriefing questions following each stated choice, respondents who said they would not
choose either offered program had the option to indicate that this was because their provincial health plan
should cover those tests.
12 The response rate for the U.S. survey was 79% (out of 3,000 initially solicited). The Canadian survey
was administered over the internet by Ipsos Reid. Our budget did not permit for a separate survey
instrument in French. Distinctions between WTP amounts in the French- and English-speaking
populations of Canada may be important, but we are not able to address that question in this study.
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respondent rejected both programs in a particular choice scenario solely because they
did not believe the program would work (rather than for “economic” reasons), the
respondent’s choice under that scenario was dropped from the analysis. Finally,
randomization of illness profiles inadvertently resulted in a small number of
implausible health profiles (about 1%), and these were dropped to preclude any
biases stemming from how they might have been interpreted.13
Although the Canadian survey was administered to the exclusively computer-
using Ipsos-Reid consumer panel, the sample is similar to the English-speaking
Canadian population on several observable dimensions. Table 1 presents a
comparison of the Canadian and U.S. samples with their respective populations.
Particularly with respect to the age distribution, the Canadian sample closely
mirrors the corresponding Canadian population. Although the Canadian sample has
fewer elderly (2% compared to 8% in the population), this is expected for a survey
administered over the internet. The income distribution for the sample is skewed
towards lower incomes compared to the population as a whole. The sample has a
greater proportion of females to males, and a slightly greater proportion of the
sample is married. Finally, although there are fewer nonwhites in the sample, the
educational attainment (those earning a college degree or more) is similar between
the sample and the Canadian population. These differences can be relevant because
one needs to allow for the possibility of systematic variation in WTP across
observable characteristics, so that differences in the types of people in the sample
are not interpreted instead as differences in preferences, for similar types of
individuals.
2 Differential patterns in health beliefs and different health care systems
Descriptive statistics presented in Table 2 show differences between the Canadian
and U.S. samples in subjective health risks, confidence in the timeliness and quality
of health care in the event of a major illness or injury, experience with going out-of-
plan for health care (for Canadians only), and attitudes about certain health-related
behaviors. Aggregating across all types of health threats addressed in the survey’s
choice sets, and across all ages, Canadian respondents perceive themselves to be
more at high risk from the types of health threats being considered in this study.
Disaggregating by type of health threat, the distributions of subjective risks remain
fairly similar, although Canadians are somewhat more likely to rate their risks as
high, and somewhat less likely to rate their risks as low.
Overall, Canadians believe there is somewhat less room to improve their health
habits by seeing a doctor more regularly, but noticeably more respondents in Canada
acknowledge that there is much room to improve their health by quitting smoking.
13 This screening results in the exclusion of 1,236 choices from the U.S. sample and 1,040 choices from
the Canadian sample due to risk comprehension failure; 2,236 choices from the U.S. sample and 393
choices from the Canadian sample due to scenario rejection; and 332 choices from the U.S. sample and 81
choices from the Canadian sample due to the unforeseen randomization error.
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With respect to getting more exercise, however, respondents in the two countries rate
their room to improve as essentially the same.
It may be important that while Canadians are somewhat less likely to say that they
have much room to improve the regularity with which they see their doctor, they are
generally less confident that their current health care provider will afford them
timely and effective diagnosis and treatment. Compared to the U.S. health care
system, the Canadian provincial health plans may afford easier access to general
practice physicians for basic care, but less access to specialists. We note that only
about sixteen percent of the Canadian subsample have gone outside their provincial
health plan specifically to obtain diagnostic tests.
The differences in health-related attitudes and beliefs between Canadian and
U.S. respondents tend to vary in interesting ways with the age of the individual.
Table 1 Demographic statistics by population and sample - Canada and U.S.
Canada U.S.
Population Sample Population Sample
Age (years)
25–44 45% 45% 47% 40%
45–64 36 41 34 39
65–74 11 12 10 14
75+ 8 2 9 7
Gender
Male 50 41 49 49
Female 50 59 51 51
Race
White 87 96 77 80
Nonwhite 13 4 23 20
Marital Status
Married 48 56 54 69
Non-married 52 44 46 31
Education
High school or less 56 58 69 70
College Degree + 44 42 31 30
Income (U.S.$1000)
10− 3 14 10 6
10–25 20 31 19 17
25–45 35 36 24 23
45–65 21 12 21 24
65–100 14 5 14 21
125+ 7 2 12 9
Source: Statistics Canada, U.S. Census Bureau, and survey data (after exclusions). Interpolation required
for income brackets (equal weight given to $5000 increments). Domestic partners in Canada counted as
married
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Appendix I provides numerous figures illustrating differences across countries, by
age, in a variety of different measures.14 These graphs greatly condense the available
information on ratings. They report age-wise means and intervals defined by plus
and minus two standard deviations, where the standard deviations are adjusted to
reflect sample size in the age group in question.15 In each figure, the triple of solid
lines applies to the U.S. sample and the triple of dashed lines applies to the Canadian
sample. As a caveat, these summary statistics treat the ordinal ratings as cardinal, so
these graphs should be considered merely as a crude way to examine apparent
variations by age level in the data.
The figures in Appendix I reveal differences in subjectively reported risks of
suffering from all seven categories of health risks addressed in our study, as well as
differences in subjectively reported room for improvement in seven types of personal
health-related behaviors. Perceived risk from Alzheimer’s disease and diabetes is
generally higher for younger (and lower for older) Canadian respondents compared
to respondents from the U.S. Perceived risk of acquiring one of five cancers
(prostate, breast, colon, lung or skin) is somewhat lower for Canadian respondents
over forty. For the risk of heart disease, younger and middle-aged Canadians
reported higher subjective risks, while older Canadians (75 years and up) reported
lower subjective risks (although this may reflect self-selection into the possibly
healthier older internet-using sample in Canada). Canadian respondents reported
substantially higher risks of acquiring respiratory disease for nearly all age groups,
with the differential inverting only for those 75 and older (with the same caveat
about the older Canadian sample). A similar pattern is seen for risk of strokes, while
little difference is seen in perceived risk of traffic accidents up until the age of
retirement, whereupon Canadians generally begin to report lower risks. Again, this
could reflect selection biases in the older internet sample in Canada.
Compared to U.S. respondents, Canadian respondents report similar abilities to
improve lifestyle habits with respect to losing weight and eating a healthier diet, but
they report generally less opportunity at all ages to use a seat belt more, or see a
doctor more regularly. Respondents from both samples report room to improve their
health by quitting smoking, but Canadian respondents younger than sixty report
more room than those in the U.S. sample. Younger Canadian respondents reported
less opportunity to reduce alcohol consumption, with the relationship reversing at
about age sixty, at which point older Canadians report considerably more
opportunity to cut back on alcohol consumption.
The disease-specific age profiles reveal some degree of correlation between
subjective beliefs about health risks and associated health habits. The higher
perception of risk for diabetes and heart disease among Canadian respondents is
correlated with a greater propensity to perceive room to reduce health risks by
exercising more. Similarly, the higher reported risk among Canadians for respiratory
disease is correlated with reports of room to improve health by quitting smoking.
However, this correlation may simply mean that Canadians who report more room to
improve their health by quitting smoking or by exercising more may translate these
15 To enhance the main trends, these three age-wise statistics are presented as twenty-year moving
averages.
14 All appendices are available online at http://pages.uoregon.edu/cameron/JRU/CDS_Appendices.pdf.
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behavioral changes as substitutes for the diagnostic testing and treatment programs
considered in the survey, for which they are therefore less willing to pay.
Alternatively, however, the risk reduction programs offered in our stated choice
scenarios may be seen as complements to these other health enhancement activities.
Finally, there are marked differences in confidence about diagnosis and treatment
of major health problems across the two systems. Canadian respondents are
generally less confident in the timeliness and quality of diagnosis and treatment
until about age seventy, but beyond this age, there is less difference in the perceived
efficacy of care. This may reflect the fact that U.S. seniors are covered by Medicare,
which is more like the Canadian provincial health plans. Regarding experience with
going outside of their provincial health plan for medical services, Canadian
respondents have, on average, gone outside of their provincial plan for about one
in five of the particular services listed in the survey question on this topic.16
However, as mentioned, only about sixteen percent of the Canadian sample has gone
outside of their health plan specifically for diagnostic testing (analogous to the risk
reduction program used to elicit willingness to pay information in the survey’s stated
choice scenarios).
3 Demand for health risk reductions: structural utility-theoretic model
The standard measure of mortality risk reduction benefits in the literature has been
the Value of a Statistical Life (VSL). This statistic measures the marginal rate of
substitution between mortality risk and income or wealth. It is common to estimate
wage-risk or wealth-risk tradeoffs (Viscusi (1993)) by assuming that the individual
considers just a single health threat, for which the risk is reduced by a small amount
in the current period (Dreze (1962); Jones-Lee (1974)). The U.S. Environmental
Protection Agency uses a one-size-fits-all VSL estimate of roughly $6–7 million.
Chestnut and De Civita (2009) provide a comprehensive review of published and
unpublished Canadian estimates of the value of mortality risk changes of different
types. In Canada, the figure has ranged from about $6.2 to $9.9 million.
It has been common in both the revealed preference (RP) and stated preference
(SP) literatures on the valuation of mortality risk reductions to point out the
limitations of a one-size-fits-all measure.17 As an alternative to the standard VSL
measure, Cameron and DeShazo (2009) build a utility-theoretic model to produce
estimates for individuals’ willingness to swap other goods and services for microrisk
reductions (i.e. risk reductions of size 10−6) for a variety of health threats. This
willingness to pay for a microrisk reduction (WTPmr) measure allows for different
valuations of health risk reductions across a variety of health states that make up a
future “illness profile” (including a pre-illness current health state, illness-years,
post-illness recovered/remission years, and lost life-years). By allowing marginal
17 Baker et al. (2008) consider the conditions on the underlying social welfare function that would be
necessary to justify the application of a single VSL estimate. They also address whether discounts or
premia might be applied to take account of age or vulnerability of the population exposed to the risk.
Sunstein (2004) raises the issue in the legal literature that VSL estimates should vary across individuals.
16 In addition to diagnostic tests, these medical services included physical exams, flu shots, major surgery,
cosmetic surgery, immunizations for children or for travel, and “other.”
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utilities to vary across the different phases of an entire illness profile, the model
integrates health states that have previously been valued in separate models or
separate studies. It also permits us to recognize that “sudden death in the current
period” is not the typical illness profile for most environmentally induced illnesses.
Most such deaths are preceded by a period of pre-mortality morbidity that may have
a substantial effect on individuals’ willingness to pay to reduce their risk of suffering
from such a health threat.
Starting from this more-general concept of WTP for microrisk reductions in the
chance of suffering from arbitrarily specified illness profiles, it is possible to extract
a special case that is close to the more-conventional VSL measure (which relates
specifically to reducing the risk of sudden death in the current period). However, the
new construct readily allows for other illness profiles which involve latency periods
and protracted periods of pre-mortality morbidity (illness-years). It depends
fundamentally upon the individual’s current age and income. Our measure is also
based fundamentally (if non-linearly) upon discounted years in each health state,
although it is still possible to solve for an analog to the “value of a statistical life-
year” (VSLY) by dividing an analog to the conventional VSL by discounted
remaining life expectancy.18
The utility-theoretic choice model in this paper is based upon a specification
described in detail in Cameron and DeShazo (2009) and the appendices to that paper,
but we offer a brief outline of the basic framework of the model in this paper. We
denote the two risk reduction programs in each choice set as A and B, and the status
quo alternative for “neither program” as N. Each program reduces the risk of facing
a specified illness profile, but involves a specified annual cost. The program cost is
assumed to apply only during pre-illness-years and recovered years, so the individual
would not pay for the program while sick (or dead) if he or she were to fall victim to
the illness or injury. An illness profile is a sequence of future health states that
includes a mutually exclusive and exhaustive combination of pre-illness-years, sick
years, post-illness recovered/remission years (if any) and lost life-years (if death is
premature). Only single spells of any given illness are described. Respondents are
assumed to maximize utility subject to their budget constraint, and thus to choose the
alternative that gives them the highest level of utility.
For simplicity, consider just the pair-wise choice between program A and N.19 We
assume that the utility of an individual, i, at time, t, depends upon net income in that
period, Yit minus the cost of any program, cit, as well as the health state they
experience in that period. In any given period, the individual will be in one of the
four possible health states, which are captured using four indicator variables: 1(preit)
for pre-illness-years, 1(illit) for illness-years, 1(rcvit) for post-illness recovered/
remission years, and 1(lylit) for life-years lost. We can write the individual’s indirect
utility function in each time period, t, as:
Vit ¼ f Yit  citð Þ þ a01ðpreitÞ þ a11ðillitÞ þ a21ðrcvitÞ þ a31ðlylitÞ þ hit ð1Þ
18 Sunstein (2003) addresses the question of whether benefit-cost analysis should employ the value of
statistical lives, or statistical life-years. VSLY calculations are explained in Moore and Viscusi (1988),
Viscusi and Hersch (2008), and Aldy and Viscusi (2008).
19 The three-way choice between two programs and neither program is analogous.
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There is uncertainty about whether the individual will actually fall sick from the
disease, so we model each choice as depending upon expected indirect utility, with
the expectation taken across the sick (S) and healthy (H) outcomes. Participation in
program A vs. N is described as altering the probability of getting sick from pNSi to
pASi (where we define this risk change as $p
AS
i ¼ pASi  pNSi ). Furthermore, each
illness profile extends through the remainder of the individual’s life expectancy, so
we discount future time periods using a constant discount rate r and discount factor
δt=(1+r)−t to get the present discounted value (PDV) of expected indirect utility for
individual i. The individual is assumed to choose program A over N if his or her
discounted expected utility is greater under A:
PDV pASi V
AS
i þ 1 pASi
 
VAHi
  PDV pNSi VNSi þ 1 pNSi VNHi  > 0 ð2Þ
The present discounted number of years making up the remainder of the




time periods spent in the pre-illness state, the recovered/remission state, and as lost



















The different health states exhaust the individual’s nominal life expectancy, so
pdveAi þ pdviAi þ pdvrAi þ pdvlAi ¼ pdvcAi . Finally, to accommodate the assumption
that each individual expects to pay program costs only during the pre-illness or
recovered post-illness periods, pdvpAi ¼ pdveAi þ pdvrAi is defined as the present
discounted time over which payments must be made.
To further simplify notation, let:
ctermAi ¼ 1 pASi
 
pdvcAi þ pASi pdvpAi
ytermAi ¼ pdvcAi  pASi pdviAi þ pNSi pdvlAi
 
ptermAi ¼ $pASi a1pdviAi þ a2pdvrAi þ a3pdvlAi
  ð3Þ
The complexity of ctermAi and yterm
A
i merely reflect the fact that net income over
the future will depend on whether the individual will be sick or dead, with
probabilities depending upon the chance of getting sick, with and without the testing
program. The abbreviation ptermAi is thus not the only term in the model that reflects
the illness profile in question.
Then the expected utility-difference that drives the individual’s choice between
programs A and N can then be defined as follows:
$PDV ES;H Vi½ 
  ¼ f Yi  cAi ctermAi  f ðYiÞytermAi þ ptermAi þ "Ai ð4Þ
The option price, in the sense of Graham (1981), is the common maximum certain
payment that makes an individual indifferent between paying for the program and
having the risk reduction, or not paying for the program and not having the risk
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reduction. Here, we solve for the common payment which makes the difference in
discounted expected utility between program A and N equal to zero:




where f ðY Þ ¼ b ﬃﬃﬃﬃYip has been selected as the best-fitting simple functional form.20
The square root form introduces some necessary curvature with respect to net
income, yet preserves the monotonic form. The expected present value of this
common certain payment can then be calculated for the individual’s remaining
lifetime and can be written as:
ES;H PV bcAi Þ  ¼ ctermAi bcAi  ð6Þ
We can divide ES;H PV c^Ai
  
by the size of the risk reduction, ΔpASi
  to get a
construct analogous to the commonly calculated Value of a Statistical Life when the
illness profile consists simply of sudden death in the current period. Scaling this
amount to an individual risk change of just 0.000001 produces an estimate of
willingness to pay for a microrisk reduction (WTPmr), typically amounting to some
small number of dollars for a 0.000001 risk reduction:
WTPmr ¼ ES;H PV bcAi Þ  $pAi   106 ð7Þ
This WTPmr is a marginal rate of substitution (the ratio of the marginal utility of
the sequence of health states to the marginal utility of income) scaled arbitrarily to a
small individual risk reduction that is more on the order of the individual risk
reductions offered by many environmental policies.21
For an illness profile consisting of sudden death in the current period (so that
pdvlAi ¼ pdvcAi ), we can divide this willingness to pay by the individual’s discounted
remaining number of life-years to yield a construct analogous to the VSLY (value of
a statistical life-year) equal to WTPmr=pdvlAi .
The marginal (dis)utility of an adverse illness profile is in the numerator of
the WTPmr, so an increase in the marginal disutility of any component of an
illness/injury profile of health states—illness-years, recovered/remission years,
and lost life-years—will increase the WTPmr. Since the marginal utility of income
is in the denominator, an increase in the marginal utility of income will decrease
the WTPmr.
To illustrate the implications of our fitted model for willingness to pay for health
risk reductions, it is necessary to choose a particular type of individual and a
particular type of illness profile. In this paper, we will focus on the illness profile that
is assumed in most wage-risk VSL studies—sudden death in the current period.
However, the WTPmr framework does allow one to simulate willingness to pay to
reduce the risk of a vast array of different illness profiles: with or without latency,
with different lengths of illness, with or without recovery, and with or without any
decrease in life expectancy.
20 Suggested by a line-search across possible Box-Cox transformation parameters.
21 Based on the arguments in Cameron (2010), we make an effort here to focus on WTP for microrisk
reductions, rather than the VSL.
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To build a distribution of WTPmr values for a particular type of health risk for a
particular population, more-general simulations would be used. It would be
necessary to specify the distribution of illness profiles that is likely to result from
the health threat, the magnitudes of the risk reductions, and the types of individuals
(ages, genders, incomes) who would be affected by these risk reductions. WTPmr
estimates could then be simulated for each of a large number of random draws from
the distributions of risks (possible illness profiles) and affected individuals to
produce a distribution of WTPmr estimates for the policy in question. In this paper,
however, we will simply illustrate the disparities in predicted willingness to pay for a
standardized illness profile, emphasizing the interpersonal and international differ-
ences in WTPmr to reduce the risk of this standard profile.
4 Empirical analysis
In Table 3, we begin with a simple four-parameter indirect utility-difference
specification (Model 1) which allows for differences between U.S. and Canadian
preferences by interacting each baseline variable with an indicator for the Canadian
subsample. Thus the first column of estimates in each pair gives the baseline
coefficient for the U.S. sample and the second column gives the differential in the
coefficient for the Canadian sample. Cameron and DeShazo (2009) have shown
that marginal utilities from discounted time in each health state depend upon the
duration of that state so we use a shifted log functional form to allow for
diminishing marginal (dis)utilities for increased lengths of time in each adverse
health state. This basic model thus includes a net income term (net of program cost,















Assuming identical error dispersions, permitting the data to be pooled, the results
for Model 1 suggest a higher marginal utility of income and considerably less
disutility from lost life-years for Canadians. As expected, for individuals from both
countries, the marginal utility of net income (i.e. other consumption) is positive (but
diminishing, given the square-root functional form). The marginal utilities associated
with each of the three adverse future health states are negative (and diminishing,
given the log functional form).22
Model 2 in Table 3 presents the results of a utility specification with ten
parameters which allows for systematic variation by age in the marginal (dis)utility
from lost life-years. We adopt a model similar to that specified in Cameron and
DeShazo (2009), which is the parsimonious version including only the statistically
22 We initially considered use of a quadratic-in-income model specification in conjunction with the
shifted-log functional form for health states. Parameter estimates from the quadratic-in-income model are
consistent with all expectations: positive and decreasing marginal utilities of income, which are positive
over the range of incomes included in the sample. However, moving to a square root functional form for
preferences over income had two advantages: 1) it prevents the marginal utility of income from ever
straying into negative territory (especially when all covariates are included), and 2) it produces superior
log-likelihood statistics. We therefore retain this restriction throughout their analysis.
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significant terms in a fully translog model (including all squares and pairwise





 þ a2 log pdvrAi þ 1 þ a3 log pdvlAi þ 1 
þ a4 log pdvlAi þ 1
  2 þ a5 log pdviAi þ 1  log pdvlAi þ 1  
" #
ð8Þ
To accommodate age, the α coefficients are allowed to differ systematically
with the respondent’s current age wherever this generalization is warranted by the
data. This leads to a model where a3 ¼ a30 þ a31agei þ a31age2i , and analogously
for α4.
23
Inclusion of age heterogeneity and more flexible functional form assumptions
certainly improves the explanatory power of our model. However, the statistically
significant difference in Model 1 in the disutility of discounted lost life-years
between Canada and the U.S. disappears in Model 2. A number of important
attitudinal differences are not reflected in this model, however. For example,
Canadian and U.S. individuals have different age profiles for attitudes about
smoking behavior, and Canadians perceive that they have less room to improve their
health habits by seeing a doctor more regularly (among other attitudinal differences
mentioned above). These differences in the two samples could be conflated with
differences in preferences across people who might otherwise seem very similar in
terms of income and age. Since the Canadian and U.S. samples also differ somewhat
along a number of demographic dimensions (such as marital status, education, and
gender), it is reasonable to expect that controlling for these differences may matter.
Additionally, as addressed in Cameron et al. (2007), our survey was designed to
elicit useful information about preferences over the stated health scenarios through
tutorials and careful explanations about how the choice tasks should be approached.
However, the potential for respondents to subjectively adjust the choice scenarios to
more closely reflect their own situation was assessed through follow-up questions. A
share of our sample appears to either over- or under-estimate the illness latency, and/
or report a different estimate of their own life expectancy than was specified in their
personal (age- and gender-indexed) version of the survey. If these extra-scenario
beliefs factor into the respondent’s selection of a most-preferred alternative, then the
effect of these various scenario adjustments could yield biases in the most important
parameter estimates. Our final model therefore includes a number of incidental
variables to control for possible “scenario adjustment” by respondents. These are
reported in detail along with the expanded version of our results provided in
Appendix VII (available online at http://pages.uoregon.edu/cameron/JRU/
CDS_Appendices.pdf).
Model 3 in Table 3 presents estimates for a specification with preferences that are
heterogenous along more dimensions than just age, where richer systematically
varying parameters replace the scalar marginal utilities of income and discounted
23 Inclusion of the squared lost life-years term enhances the flexibility of the specification. The interaction
term between illness-years and lost life-years allows the marginal disutility from a discounted lost life-year
to depend upon the number of preceding sick-years. It is possible that the value of an incremental life-year
is diminished by a preceding serious illness (with the prospect of pain and disability and a loss of self-
sufficiency). An illness that is sufficiently severe, long-lasting, and terminal may indeed be a fate worse
than death.
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future health states (β and α1 through α5).
24 The key results for Model 3 are the
marginal utility parameters from a parsimonious specification where additional
socio-demographic and attitudinal covariates are interacted with the net income
terms and our illness-state variables. As for Models 1 and 2, the second column of
coefficients for Model 3 gives the coefficient differentials on interaction terms
involving the Canadian-sample indicator variable. The estimates in the final column
in Table 3 clearly show that there are differences between Canadian and U.S.
preferences with respect to the attributes of the illness profiles.
Before reviewing the estimates for Model 3 and their implications for WTPmr, we
emphasize the endogeneity of the subjective risk variables, people’s health habits,
their confidence in their current health care, and, for Canadians, whether they have
ever gone outside their provincial health plan for care. The estimated coefficients on
interaction terms involving these variables thus imply only that a relationship exists,
not that causality has been established. Coefficients with plausible signs, however,
imply a degree of “theoretical construct validity” for our estimates, in that variations
in WTP for health risk reductions are consistent with intuition.
In Table 3, recall that the coefficients on variables which are interacted with the
net income term reveal the sign of the effect of each variable on the β parameter, and
hence on the marginal utility of income. This marginal utility appears in the
denominator of the WTPmr formula, so anything that makes the marginal utility of
income larger will tend to reduce WTPmr for a reduction in the risk. In contrast,
variables which shift any of the α parameters affect the numerator of the WTPmr
formula. In the following sections, we will discuss the effects of heterogeneity,
across individuals and between the two countries, by category of variable.
4.1 Effects of subjective risks
Subjective risks of illness affect the marginal utility of income (and thusWTPmr) via the
β parameter. These subjective risks appear to have different influences for Canadians
and U.S. respondents.25 A high subjective risk of the illness profile in question results
in a lower marginal utility of income for all respondents (and hence contributes to a
higher WTPmr to reduce the risk of that illness). Respondents in the U.S. who report
moderately low subjective risks for the illness in question have a WTPmr that is not
distinguishable from that for individuals who have either moderate or very low
subjective risks. However, Canadians who report a moderately low subjective risk of
the illness in question can be discerned to have a systematically higher marginal utility
of income and thus a lower WTPmr to reduce the risk of that illness.
Subjective risks also influence willingness to pay for health risk reductions via the
α1 and α3 parameters on the illness-years and lost life-years terms, but these effects
24 The complete sets of estimates for all three models in Table 3, including a variety of incidental
parameters, are provided in Appendix VII.
25 Our analysis maintains the hypothesis that the error variances are the same for both the U.S. and
Canadian samples. Since the survey instruments are virtually identical, this may be a reasonable
assumption. If we were to find that the U.S. and Canadian coefficients were proportional, of course,
different error variances would be the first thing to suspect, but the parameters do not appear to be
proportional. Relaxing the assumption of equal error variances would require specially designed maximum
likelihood estimators, so we leave that issue for future work.
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seem to be similar in Canada and the U.S. For both health states, and for both
countries, a high subjective risk for the illness in question increases the disutility
associated with illness-years and lost life-years and thus increases the value attached
to a reduction in the risk of suffering from that particular health threat. A perception
of being at lower risk reduces the value.26
4.2 Effects of confidence in effective and timely treatment
Respondents in the U.S. who are “highly confident” that diagnosis and treatment by
their current health care provider would be both timely and of high quality have a
higher marginal utility of income, via the β parameter, and thus have lower WTP to
reduce the risk of any type of illness profile. These individuals may view the offered
diagnostic programs as substitutes for their existing health care services. However,
Canadians who are “not at all confident” in the timeliness and efficacy of their
current health care also have a higher marginal utility of income and therefore a
lower WTP to reduce their risk of any type of illness profile. There are no
statistically significant effects of age on the marginal utility of income in our model.
Thus the U.S. effect may reflect the influence of retirees with low current income but
access to Medicare. In Canada, however, a lack of confidence in the health care
system could be related to lower-income rural areas with limited access to
physicians.
Via the α3 parameter, having confidence in the timeliness and quality of diagnosis
and treatment has a positive effect on the value attached to avoiding early death for
U.S. respondents, but it appears to reduce the value from avoided premature death
for Canadians. For residents of both countries, a lack of confidence in the health care
system seems to reduce the marginal value attached to reductions in lost life-years.
This suggests that people may not wish to prolong their lives so much if they are not
sure what quality-of-life will be offered by the health care they will be able to enjoy.
For the U.S., greater confidence in the timeliness and quality of care may translate
into higher willingness to pay for diagnostic tests that will help avoid lost life-years,
but the effect is not statistically significant. For Canadians, however, greater
confidence in timely and high-quality care seems to reduce the marginal value
attached to lessening the risk of early death.
4.3 Effects of respondent age
Our results with respect to the effect of respondent age on preferences over lost life-
years are particularly interesting. In general, age effects tend to be smaller in
absolute value for Canadians, and relatively more pronounced for U.S. residents.
Respondent age affects both the baseline marginal utility of lost life-years, α3, as
well as the coefficient on the squared term in the shifted logarithm of discounted lost
life-years, α4. Put simply, older individuals seem to value lost life-years less, with
26 Van Houtven et al. (2008) offer a recent national survey that distinguishes between accident-related
deaths and cancer deaths, noting the presence of a cancer premium. Different types of health threats may
be more or less salient to different respondents, which may be due to different subjective risks of these
different illnesses.
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the value of any individual lost life-year decreasing in the number of years lost
overall. For Canadians, however, this age effect is almost (though not completely)
offset by opposite signs on the shift coefficients, suggesting that at least for our
sample, Canadians exhibit smaller age effects. However, due to the variety of ways
in which age enters the model, simulations are necessary to illustrate the net effects
of the eight statistically significant age coefficients in Model 3.
4.4 Other factors affecting the marginal utility of sick-years, recovered/remission-
years, and lost life-years
The α1 parameter on the term in discounted sick-years is expected to be negative,
since prospective sick-years confer disutility. Canadians, in general, get more
disutility from sick-years than do U.S. respondents, so they value avoided illness-
years considerably more than do individuals in the U.S. For both countries, however,
higher subjective risks of disease amplify the marginal disutility of illness-years and
increase WTPmr for the risk-reduction program. Females in both countries have lesser
aversion than males to illness-years and are therefore willing to pay less, while
respondents who admit that they could improve their health habits with more
exercise derive greater disutility from illness and are willing to pay more for these
diagnostic and treatment programs. They may view these programs as substitutes for
better health habits. For Canadians, smoking status also appears to have a strong
relationship to the marginal disutility of becoming sick. Those who report very little
room to improve their health habits by quitting smoking have substantially smaller
disutilities associated with illness-years. We assume that these people are non-
smokers or infrequent smokers (or smokers who do not believe that their health is
adversely affected by smoking). These individuals are willing to pay less for the
offered programs.
For the α2 parameter for both countries, males tend to assign little marginal value
to reducing the number of recovered/remission years, while women from both
countries (and the U.S. in particular) are willing to pay to avoid recovered/remission
years. This provides an interesting contrast: for women, morbidity is apparently still
expected to be present in the recovered/remission state following one of these major
illnesses, whereas men appear to perceive recovered/remission years as a fully
recovered state that provides a level of utility equivalent to their pre-illness state.
Men appear to attach value only to avoided illness-years and avoided lost life-years.
The sociodemographic and attitudinal variation in the α3 parameter shows that
females appear to derive less disutility from lost life-years than do males, and even
more so in Canada than in the U.S. Combined with a higher marginal utility of net
income for women, this will tend to reduce their WTPmr for mortality risk reductions.
Having a college degree increases the marginal value attached to lost life-years,
while being non-married reduces it; however, this effect is present only for U.S.
respondents, with the point estimates on the Canadian interaction terms almost
exactly offsetting the effect. For Canadians, having had some previous experience with
going outside of their provincial health plan for diagnostic testing has a weakly
significant and positive effect on the disutility of lost life-years, so that these individuals
are willing to pay more for health risk reductions when the health threat involves
premature death. Finally, individuals who feel they have little room to improve their
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health habits by seeing a doctor more regularly are more willing to pay to reduce their
risks of lost life-years. These people may be more health-conscious in general.
Canadians and U.S. respondents exhibit strikingly different coefficients on the
interaction term between illness-years and lost life-years. While U.S. respondents
derive greater disutility from lost life-years after a longer period of illness, the
opposite effect seems to be present in Canada. For Canadians, the disutility from lost
life-years is reduced as the number of preceding illness-years increases. Thus, in
Canada, it may be the case that a long period of illness may evolve into a “fate worse
than death,” whereas in the U.S., the average individual may want to prolong life no
matter how bad an illness gets.27
4.5 Implications
Model 3 illustrates the importance of including a rich set of attitudinal and
demographic controls when modeling differences in preferences across jurisdictions.
When there are unequal relative frequencies for different types of respondents in the
two countries, failure to control for individual heterogeneity could easily distort the
coefficients on the interaction terms involving the indicator for the Canadian
subsample. Table 1 reveals that Canada has a higher proportion of non-married
individuals, and a higher proportion with a college degree or more (despite lower
Canadian incomes).28 These sociodemographic variables have significant effects on
the estimated magnitude of the marginal disutility of a lost life-year, but these effects
also differ across countries.
5 Simulation results
Based upon our preferred specification (Model 3), we explore a number of simulations
of the fitted distribution ofWTP for a 10−6 reduction in the risk of sudden death. This is
also known as a “microrisk reduction” (μr) or, in this special case of an illness profile
consisting of sudden death, as a “micromort”). We differentiate our fitted age profiles
for Canadian and U.S. respondents, for males and females, for individuals with and
without a college education, and for those who are married or not married.
Additionally, for Canadian males, we simulate WTPmr for those with and without
experience with out-of-plan diagnostic testing procedures. All dollar-denominated
amounts in our study are converted to U.S. dollars (circa the first quarter of 2003).29
27 If we allow the coefficient α5 to vary with the respondent’s level of confidence in their current health
care, there is weak evidence (i.e. at only an 11% level of significance) that greater confidence may actually
lessen the disutility associated with lost life-years for each additional year of prior morbidity. Thus the
distinction between U.S. respondents and Canadians does not seem to be merely an artifact of Canadians’
lesser confidence in their health care.
29 We convert the value of a Canadian dollar into equivalent U.S. dollars, using the contemporaneous
interbank exchange rate as of 12/01/02, equal to $0.63902. The Canadian sample was collected first, at the
end of 2002. The U.S. sample was collected early in 2003, so we refer to all dollar amounts as “2003 US
dollars.”
28 However, the implicit value of the provincial health plans is not included in the Canadian income data.
Differences in the proportion of non-whites in the self-reported data for the two countries appear to be
unimportant. This variable had no robustly statistically significant effect on any of the utility parameters.
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Our simulations are benchmarked for average sample income in the U.S. (roughly
$42,000 U.S.). We assume a discount rate of 5%, and we focus on the illness profile
consisting of sudden death in the current period (i.e. death with no latency and no
prior illness) so that our model’s predictions can be compared to standard VSL
estimates. Fitted WTPmr based on Model 3 is calculated with subjective and
attitudinal variables simulated at their baseline (i.e. omitted-category) values. These
subjective and attitudinal variables include perceived risk of the illness or injury in
question, room to improve health by increasing exercise, quitting smoking, and
seeing a doctor more regularly, and confidence in diagnosis and treatment under
Canadian or U.S. health systems.30
5.1 WTPμr to reduce a risk of sudden death (by age of respondent)
For each type of simulation, we vary age in five-year increments from 25 to 80 years
to permit us to graph the implied age profile. In each case, we make 1,000 random
draws from the asymptotically joint normal distribution of the maximum likelihood
parameter estimates. This variability in parameter values, in combination with
specified values for each of the explanatory variables which appear in the model,
allow us to generate a “sampling distribution” for WTPmr that reflects the degree of
precision in the estimated parameters.
Appendices II through VI (available online at http://pages.uoregon.edu/cameron/
JRU/CDS_Appendices.pdf) present graphs of the age profiles of our simulation
results—broken out by gender, educational attainment, marital status, and out-of-plan
experience. Individual figures show either (a.) the median (solid line) and 5th and
95th percentiles (dashed lines) for 1,000 draws from the estimated joint distribution
of parameters calculated at each five-year age level between 25 and 80 years, or (b.)
just the median simulated value, for each of several different types of individuals,
permitting us to compare age profiles for WTPmr across the different groups.
The age profile of WTP for a microrisk reduction in the chance of sudden death is
considerably different for the Canadian and U.S. samples. Canadians, regardless of
gender, education, or marital status, have a flatter age profile of WTPmr to reduce risk
of early death, with peak WTPmr realized at a substantially older age (around age 60
for Canadians compared to age 35–40 for individuals from the U.S.). In general,
Canadians are willing to pay more at older ages, but U.S. respondents are willing to
pay more at younger ages. Across the 1,000 sets of parameter draws, peak median
WTPmr for Canadians males is only $8.71 annually (at age 60), compared to $10.46
for males from the U.S. (at age 35–40). Females have substantially lower WTPmr for
sudden death regardless of country of residence: we find a peak median WTPmr of
only $3.04 for Canadian females (age 60), but $5.72 for U.S. females (at age 35–40).
These age profiles are shown in Fig. 2 for U.S. and Canadian males and females.
30 It is essential to use ctermji and yterm
j
i to explain respondents’ stated choices among the privately paid
diagnostic testing programs used in our choice scenarios. For public policies to reduce risks, however,
people may expect to keep paying the cost of the policy even if they get sick, and they may not consider
the chance that premature mortality could free them from paying the cost of the policy but leave them with
no other consumption either. For benefits transfer, it may thus be appropriate to assume
ctermji ¼ ytermji ¼ pdvcji. Here, however, we simulate WTPμr using the forms in (3), with pNSi and pjSi
arbitrarily set to .004 and .001.
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5.2 Comparisons to the literature on VSLs
The illness profile in question is sudden death in the current period, so multiplication
of these WTPmr amounts by one million will yield a number roughly comparable to
standard estimates of the value of a statistical life (VSL). Several meta-analyses of
VSL estimates in general have been conducted, including Mrozek and Taylor (2002),
Viscusi and Aldy (2003), and Kochi et al. (2006), but we focus here on the literature
on VSLs as a function of age. Aldy and Viscusi (2008) determine from cohort-
adjusted age-specific hedonic wage equations that workers’ VSLs start at $3.39
million at age eighteen, rise to a peak of $7.79 million at age 46, then decline again
to $5.09 million at age 62, the highest age in their sample of workers.
Our general-population sample of U.S. respondents suggests WTPmr estimates
corresponding to a VSL at age 25 of about $9.36 million for males and about $5.01
million for females. (The youngest respondents in our sample are 25 years old. We do
not attempt any out-of-sample simulations for age eighteen, but our model suggests that
VSLs would be smaller at age eighteen than at age 25.) Values peak around age 35–40
at about $10.46 million for males and $5.72 million for females. Then they decline by
age 65 to about $5.83 million for males and $3.08 million for females. Thus our
general population male and female estimates appear to bracket the VSL estimates of
Aldy and Viscusi (2008) at those ages where our estimates can be roughly compared.31
We certainly find noticeable differences between the U.S. and Canada. This
contrasts with the results of Chestnut et al. (2009), where no statistically significant
differences between the two countries are found.
31 The question of age profiles of WTP to reduce mortality risks is also addressed in Krupnick (2007) and
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Respondent's age now
US males Cdn males
US females Cdn females
(sudden death, current period; income = $42K, r = 0.05)
Fig. 2 Male and female age profiles for median WTP in the U.S. and Canada (see Appendix II for 5th and
95th percent intervals around each median. Appendices available online at http://pages.uoregon.edu/
cameron/JRU/CDS_Appendices.pdf)
J Risk Uncertain (2010) 41:245–273 269
5.3 Comparisons to the literature on VSLYs
We have also calculated the corresponding age profiles of our analog to the value of
a “statistical life-year” (VSLY). Our estimates for the average WTPmr per discounted
lost life-year are shown in Fig. 3, with simulated confidence intervals provided in
Appendix III. As in Aldy and Viscusi (2008), these profiles take an inverted
U-shape. In the U.S., the simulated medians of these average values peak around
age 40, whereas the peak in Canada is between the ages of 65 and 70. The
maximum value for U.S. males is about $0.55 (implying a VSLY of $550,000), but
the values range from $0.47 at age 25 to $0.02 at age 80. For U.S. females, the
maximum value is only about $0.30, although the estimates range from $0.25 at age
25 to $0.08 at age 80. Canadian values peak later, at about age 65 to 70. The peak
for Canadian males is about $0.57, whereas the peak for Canadian females is only
about $0.19.
The VSLY numbers implied by our simulations can be compared to those
produced in Aldy and Viscusi (2008). For the U.S., our peaks for males of $550,000
(in 2003 U.S. dollars) and for females of $300,000 occur at about age 40. Aldy and
Viscusi’s basic measure (calculated for a discount rate of 3%, rather than our 5%
rate) peaks at a value of $375,000 at age 45. Their cohort-adjusted measure peaks at
a value of $401,000 (in year 2000 dollars) at age 54. Aldy and Viscusi’s sample is
limited to workers and appears to include both males and females without
differentiation, so that one would expect the peak to be lower for their data (since
their model pools both genders and uses earlier dollars) than for our results for U.S.
males. Thus our results for a construct similar to the VSLY seem reasonably
















25 35 45 55 65 75
Respondent's age now
US males Cdn males
US females Cdn females
(sudden death, current period; income = $42K, r = 0.05)
Fig. 3 Male and female age profiles for median WTP per discounted lost life-year, in the U.S. and Canada
(see Appendix III for 5th and 95th percent intervals around each median. Appendices available online at
http://pages.uoregon.edu/cameron/JRU/CDS_Appendices.pdf)
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5.4 Heterogeneity in age profiles for WTPmr
Returning to the overall WTPmr estimates, we can consider other sources of
heterogeneity besides age by looking at additional factors which shift the age profile
of WTPmr. We have already shown that males in the U.S. sample are willing to pay
more for health risk reduction programs. The age profiles in Appendices II through
VI show that respondents who are married and have a college degree tend to have
substantially higher WTPmr than non-college-educated and unmarried respondents in
the U.S., but not in Canada. Peak median WTPmr for college-educated males in the
U.S. is about $13.59, and for unmarried males in the U.S. it is only $7.62 (both at
about age 35). By contrast, peak median WTPmr is $8.55 for college-educated males
in Canada , and $8.99 for those who are unmarried (both at about age 55).
A notable result is that the difference between peak Canadian male WTPmr and
peak U.S. male WTPmr amounts is reduced substantially by Canadian experience
with out-of-plan medical diagnostic tests. Peak median WTP for Canadian males
with out-of-plan experience jumps to $11.89 (at about age 60), with a fairly wide
confidence band, and is well within the 90% interval for the U.S. peak for males at
age 35–40.
6 Conclusions
This study has shown that failure to control for individual heterogeneity, in the
presence of different types of respondents in the U.S. and Canada, can easily distort
the coefficients on the interaction terms involving the indicator for the Canadian
subsample. Different patterns in sociodemographic and attitudinal heterogeneity
across the two countries account for a good deal of heterogeneity in choice behavior
in our study, but there remain many dimensions where there are further differences
that we can so far attribute only to the difference in jurisdictions. Of course, there
may still be other factors which differ across jurisdictions (e.g. other cultural
differences) which we have not observed in this study and are therefore unable to use
as controls.
The insights from our analysis raise many important questions about differences
between the U.S. and Canada in individual demands for health-maintenance
programs (and, by analogy, reductions in environmental health risks). As always,
further independent research will help add to the weight of evidence concerning our
findings, but our results seem to suggest the following.
For Canadians, experience with private health care options outside their
provincial health plans may be correlated with preferences that correspond more
closely to those held by U.S. residents. Some Canadians worry that encroachment of
private health care options in Canada will spoil universal health care. Thus there may
be reason to worry that people who self-select to go outside their provincial plans
may already have preferences more like U.S. preferences.
Canada’s provincial health plans mean that the implicit annual value of this health
insurance is not included in measured income. Canadians’ lower willingness to pay
for health risk reductions in this study might seem lower yet if these amounts were
associated with incomes that were actually higher by the implicit value of the
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publicly provided health coverage. Peak willingness to pay for mortality risk
reductions also occurs at much older ages in Canada, even controlling for a wide
range of other attitudinal and subjective risk factors that are correlated with age to
some extent.
Until they reach age 60, Canadians appear to be generally less confident that they
will receive timely and effective medical care, compared to their U.S. counterparts,
but their confidence levels seem to increase markedly after age 60. Despite this lack
of confidence among younger Canadians, compared to U.S. residents, these
respondents do not feel as much like they could improve their health habits by
seeing a doctor more regularly. Thus, despite the perception in the U.S. that the
Canadian health care system involves long queues and delays in seeing specialists,
Canadians may not feel that they see their primary care physicians too infrequently.
Greater confidence in the timeliness and efficacy of health care, for Canadians,
tends to reduce their average willingness to pay for diagnostic testing programs to
reduce the risk of lost life-years. In the U.S., however, greater confidence seems to
increase willingness to pay for these same types of programs. This may reflect
different attitudes towards preventive medicine. Canadians may view it as a
substitute for later treatment, while U.S. residents may see preventive testing as a
complement to treatment.
Finally, our results may explain different expectations, across the two countries,
concerning entitlement to end-of-life interventions without regard to cost. The effect
of additional years of pre-mortality morbidity on an individual’s willingness to pay
to reduce the risk of lost life-years appears to have the opposite sign in the U.S. and
Canada. Additional prior morbidity appears to raise WTP for mortality risk
reductions in the U.S., but lowers it in Canada.
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